A little over a year after the dissolution of the once high-flying blood testing startup Theranos, another startup has raised over $27 million to breathe new life into the vision of bringing low-cost blood tests to point-of-care medical facilities. Unlike Theranos, Truvian Sciences is not claiming that most of its blood tests do not need […]...